Search the Newsreel

Cetera Investment Advisers Buys Shares of 15,819 Gorman-Rupp Company (The) $GRC

Cetera Investment Advisers initiated a new position in Gorman-Rupp Company, purchasing 15,819 shares valued at approximately $983,000, which represents 0.06% of the company. Institutional investors collectively own 59.26% of Gorman-Rupp. The company recently reported quarterly earnings of $0.74 per share, exceeding analyst estimates, and …

Value Partners Investments Inc. Reduces Holdings in Thermo Fisher Scientific Inc. $TMO

Thompson Investment Management Inc. Increases Stock Position in Meta Platforms, Inc. $META

Amylyx Pharmaceuticals (AMLX) Stock Trades At A Premium After Avexitide Trial Progress

Amylyx Pharmaceuticals (AMLX) stock has seen a 170.4% return over the past year, but its valuation metrics suggest it is trading at a premium. The progress of the avexitide trial, including its completed pivotal trial and potential commercial launch, supports future cash flow expectations, …

Redcare Pharmacy Aktie • A2AR94 • NL0012044747

Madrigal’s Rezdiffra Hits $1.3B Run Rate as MASH Pipeline Expands

Madrigal Pharmaceuticals' drug Rezdiffra achieved a $1.3 billion trailing-12-month revenue run rate in Q2 2026, with revenue up 71% year-over-year and over 49,000 active patients. The company is expanding its MASH pipeline to 10 assets, primarily for combination with Rezdiffra, targeting weight loss, liver-fat …

Wedge Capital Management L L P NC Buys Shares of 128,845 Theravance Biopharma, Inc. $TBPH

Wedge Capital Management L L P NC recently acquired 128,845 shares of Theravance Biopharma (NASDAQ:TBPH) worth approximately $2.19 million, now owning about 0.25% of the company. Institutional investors hold 99.10% of TBPH, despite the company reporting an adjusted loss and missing revenue expectations in …

Permian Resources (PR) Stock Still Looks Cheap On Earnings While Broader Checks Stay Mixed

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Permian Resources has delivered a very large 5 year return, yet its current checks on valuation offer a more measured read, with the …

Security National Bank Boosts Stock Position in Thermo Fisher Scientific Inc. $TMO

Security National Bank increased its stake in Thermo Fisher Scientific Inc. (TMO) by 18.5% in the second quarter, bringing its total holdings to 14,095 shares valued at approximately $7.1 million. The article also notes that institutional investors own 89.23% of TMO, and analysts generally …

Milestone’s FDA Win Now Faces A Tougher Test: Sales

Milestone Pharmaceuticals (NASDAQ: MIST) recently gained FDA approval for its lead product, CARDAMYST™ (etripamil) nasal spray, for PSVT. However, the company now faces the challenge of commercializing the product, with early sales and market sentiment being mixed. The success of CARDAMYST depends heavily on …

How Securities Lawsuits Over Trial Disclosures Will Impact Regeneron Pharmaceuticals’ (REGN) Pipeline-Driven Investment Story

Regeneron Pharmaceuticals is facing securities class action lawsuits concerning alleged misleading statements about its Phase III Fianlimab-Libtayo trial. These lawsuits, focusing on disclosure practices regarding trial delays and failure, could influence investor perception of Regeneron's pipeline-driven strategy, especially as the company advances new programs …

Brown Shipley& Co Ltd Purchases 1,857 Shares of Meta Platforms, Inc. $META

Empowered Funds LLC Buys 119,202 Shares of Arrowhead Pharmaceuticals, Inc. $ARWR

Empowered Funds LLC significantly increased its stake in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) by 661.6% in the first quarter, adding 119,202 shares to reach a total of 137,220 shares valued at $8.6 million. This move is part of a broader trend of institutional investment, with …

Cannon Advisors Inc. Acquires New Shares in Thermo Fisher Scientific Inc. $TMO

Cannon Advisors Inc. recently purchased 3,971 shares of Thermo Fisher Scientific Inc. (NYSE:TMO) valued at approximately $2.12 million, making it their 17th biggest position. This acquisition comes as other hedge funds have also adjusted their holdings in TMO, while company insiders have sold a …

Canoe Financial LP Buys 148,999 Shares of Thermo Fisher Scientific Inc. $TMO

IONS Stock Jumps 4% After-Hours — Goldman Sachs Lifts Price Target On Tryngolza Approval

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Consensus Rating of "Moderate Buy" from Analysts

NRx Pharmaceuticals (NASDAQ:NRXP) has received a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of $34.50. Despite this, the company recently missed its quarterly earnings and revenue estimates. Hedge funds and institutional investors hold 4.27% of the stock.

Bank of America Corp DE Boosts Stake in Kiniksa Pharmaceuticals International, plc $KNSA

Connect Biopharma (NASDAQ:CNTB) Upgraded by Wall Street Zen to Hold Rating

Wall Street Zen has upgraded Connect Biopharma (NASDAQ:CNTB) from a "sell" to a "hold" rating, though the broader analyst consensus remains a "Moderate Buy" with an average price target of $7.43. The company recently reported a quarterly loss of $0.27 per share, outperforming expectations, …

Vertex (VRTX) Stock Looks Above Fair Value On Earnings Yet About Right Overall

Vertex Pharmaceuticals (VRTX) has seen strong multi-year performance, with a 158.2% return over the past five years, but its current valuation suggests it's neither a clear bargain nor obviously overvalued. The stock trades at 29.1x earnings, slightly above Simply Wall St's fair P/E estimate …

ARWR Stock Clocks Best Day In Nearly 8 Months As Analyst Lifts Price Target On Plozasiran Data

How (HASI) Movements Inform Risk Allocation Models

This article analyzes Hannon Armstrong Sustainable Infrastructure Capital Inc. (NASDAQ: HASI) using AI models, indicating strong sentiment across all horizons and an exceptional 25.3:1 risk-reward setup. It outlines specific institutional trading strategies (Position Trading, Momentum Breakout, and Risk Hedging) with entry, target, and stop-loss …

Sprouts Farmers Market, Inc. (NASDAQ:SFM) Given Consensus Recommendation of "Hold" by Brokerages

Brokerages have given Sprouts Farmers Market (NASDAQ:SFM) a consensus "Hold" recommendation, with an average 12-month price target of $91.58 among 14 analysts. While the company recently exceeded earnings and revenue expectations, analysts noted softer comparable sales and margin pressure, leading to some reduced near-term …

Wall Street Zen Upgrades Regeneron Pharmaceuticals (NASDAQ:REGN) to Strong-Buy

Wall Street Zen has upgraded Regeneron Pharmaceuticals (NASDAQ:REGN) from a "buy" to a "strong-buy" rating. This upgrade follows Regeneron's strong quarterly earnings, where it surpassed analyst expectations for both EPS and revenue. Despite positive news regarding pipeline expansion and collaborations, the company faces risks …

German American Bancorp (NASDAQ:GABC) Stock Crosses Above Two Hundred Day Moving Average - What's Next?

NewAmsterdam Pharma (NAMS) Earnings Losses Raise The Question Of Whether The Stock Is A Bargain

Under Armour (UAA) Stock May Trade At A Premium On Cash Flow But A Discount On Sales

RMC Switchgears Q1 Results: Net profit up 116.8% YoY to ₹918.5 crore

Inovio Pharmaceuticals (NASDAQ:INO) Upgraded to "Hold" at Wall Street Zen

Wall Street Zen has upgraded Inovio Pharmaceuticals (NASDAQ:INO) from a "Sell" to a "Hold" rating, though overall analyst opinions remain mixed, with MarketBeat reporting a "Moderate Buy" consensus. The company recently exceeded earnings estimates, reporting a quarterly EPS of negative $0.07 against an expected …

Under Armour (UAA) Stock Looks Overvalued Relative To Fair Value

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Under Armour stock is coming off a difficult stretch, with the share price down about 77.1% over the past five years, while the valuation checks …

Ermenegildo Zegna (NYSE:ZGN) Stock Rating Lowered by Wall Street Zen

Wall Street Zen has downgraded Ermenegildo Zegna (NYSE:ZGN) from a "buy" to a "hold" rating, contributing to a mixed analyst sentiment with an overall "Hold" consensus and an average price target of $13.13. Despite this, other analysts like TD Cowen, UBS Group, and JPMorgan …

Why Xeris Biopharma Holdings (XERS) Is Up 8.4% After Tightening 2026 Revenue Guidance And Advancing XP-8121

Armstrong World Industries, Inc. (NYSE:AWI) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Armstrong World Industries, Inc. (NYSE:AWI) has received a consensus "Moderate Buy" rating from analysts, with an average 12-month price target of $213. The company recently surpassed quarterly expectations with $2.36 EPS and $472 million in revenue, an 11.2% year-over-year increase. Additionally, Armstrong reaffirmed its …

Eledon Pharmaceuticals (NASDAQ:ELDN) Upgraded at Wall Street Zen

Wall Street Zen upgraded Eledon Pharmaceuticals (NASDAQ:ELDN) from "strong sell" to "sell," though the broader analyst consensus remains "Hold" with a $9.67 target price. The company reported a quarterly loss of $0.27 per share, missing estimates, and its shares opened at $3.54. Institutional investors …

Oramed Pharmaceuticals (NASDAQ:ORMP) Upgraded by Wall Street Zen to Buy Rating

Wall Street Zen has upgraded Oramed Pharmaceuticals (NASDAQ:ORMP) from a "hold" to a "buy" rating, though MarketBeat's overall analyst rating for the company remains "Hold." Oramed Pharmaceuticals opened at $4.48, with a market capitalization of $186.35 million. The company recently reported a quarterly loss …

NervGen Pharma (NASDAQ:NGEN) Stock Rating Lowered by Wall Street Zen